Mr. Leo Yun-Ting Tsou is currently the Vice President at WISPRO, who focuses on Bio-industry and Life Science. He has expertise in planing IP strategy for different bussiness model. Leo has handled consulting projects for more than 60 clients in bio-industry worldwide. His professional experiences incude coordination of R&D and IP mechanisms for pharmaceutical company, IP Portfolio Management, Patent Risk Management, IP Due Diligence for Investment, IP Monetization, Tech transfer/IP Licensing, and Technology/Industry Intelligance.

Education

Master degree in Microbiology and Immunology, National Yang Ming University
Biotechnology Management Program, Join-program of National Yang Ming University and National Chengchi University
Bachelor degree in Microbiology and Plant Phathology, National Taiwan University

Professional Activities

Lecturer (2021), Innovation and Entrepreneurship Program, by National Quemoy University
Lecturer (2021), IP Deployment Stategy and Patent Risk Accessment in Biomedical Field, Intellectual Property Seminar, by China Medical University
Lecturer (2021), Coordination of R&D and IP Mechanisms in Biomedical Field, Far Eastern Memorial Hospital
Lecturer (2021), Multi-Disciplinary Management of Technology Training Program for Senior Personnel, MMOT, by Cornerstone Intellectual Property Foundation
Lecturer (2021), Purpose, Methods and Tools for IP Due Diligence in Biopharma Industry, by National Health Research Institutes
Lecturer (2021), How to Use AI Patent Intelligence for Gathering Insights and Managing Patent Portfolio, by National Health Research Institutes
Lecturer & Course Planner (2018-2020), Biotech Industrial IP Management, Biotech Industrial Academy
Lecturer (2020), Innovative Medical Devices Manager Course, Industrial Technology Research Institute
Lecturer (2020), , Industrial Development Bureau

Lecturer, Multi-Disciplinary Management of Technology Training Program for Senior Personnel, MMOT, by Cornerstone Intellectual Property Foundation
Lecturer(2015~2016), Intellectual property and international business law in medical device industry, a 3-credit course by National Cheng Kung University(NCKU)
Lecturer(2015), Innovation and business model of big data of patent and M&A, a 3-credit course by Soochow University(SCU)
Co-principal Investigator(2016-2019), Enhancement and value-added project for patent search by Industrial Development Bureau, Ministry of Economic Affairs (IDB, MOEA)
Keynote speaker(2019), China Intellectual Property Policymakers Summit in Shenzhen
Advisory committee member(2018~2022) of administrative affairs in department of Engineering and Systems Science, National Tsing Hua University
Advisory Committee Member(2021~2022) of MIH Consortium

Primary Practices

Coordination of R&D and IP mechanisms for pharmaceutical company,
IP Portfolio Management,
Patent Risk Management,
IP Due Diligence for Investment,
IP Monetization,
Tech transfer/IP Licensing, and
Technology/Industry Intelligance

Industries

Pharmaceutical, Biotechnology, Patent Linkage, Immunotherapy, Genetic and Genomic Testing, IVD, Medical devices

Publications and Insights

The Race for Coronavirus Vaccine Development: Beware of Entering Into Future Patent Wars，2020/8/12，Wispro Insights
一生只需打一次的流感疫苗？利用专利信息盘点通用流感疫苗公司，IPR Daily，2020/3/4刊登
从吉利德专利布局解读其瑞德西韦之产品布局，IPR Daily，2020/2/12
專利連結三讀通過 學名藥廠化危機為商機，工商時報，2018/1/23刊登
進軍美國生物相似藥 專利舞蹈如何跳，工商時報，2016/8/3刊登
进军美国生物类似药市场，突破原研药厂的专利壁垒，生物谷，2015/12/1刊登
美国生物类似药专利舞蹈跳或不跳之专利法律评析，生物谷，2015/11/10刊登
Human CLEC18 gene cluster contains C-type lectins with differential glycanbinding
specificity, Journal of Biological Chemistry, 2015/7/13